Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Ablation Methods for Ventricular Tachycardia Ablation. Part 2
Author(s): Maria Niespialowska-Steuden , John Silberbauer , Jaffar Al-Sheikhli , et al Added: 1 week ago

Electrophysiology & Arrhythmia
Ablation Methods for Ventricular Tachycardia Ablation. Part 1
Author(s): Maria Niespialowska-Steuden , John Silberbauer , Jaffar Al-Sheikhli , et al Added: 1 week ago

Electrophysiology & Arrhythmia
Complications of Pulsed Field Ablation for AF
Author(s): Francis J Ha , Tai Ermongkonchai , Hui-Chen Han , et al Added: 4 weeks ago

Electrophysiology & Arrhythmia
Complication Prevention in Complex AF and VT Procedures
Author(s): Pasquale Santangeli , Dhanunjaya Lakkireddy Added: 3 months ago
Dr Dhanunjaya Lakkireddy (Kansas City Heart Rhythm Institute, Kansas City, US) and Dr Pasquale Santangeli (Cleveland Clinic, Cleveland, OH, US) discuss evidence-based strategies for preventing complications during complex atrial fibrillation and ventricular tachycardia ablation procedures.This expert discussion focuses on safety considerations in high-risk electrophysiology procedures, comparing… View more

Electrophysiology & Arrhythmia
VT Ablation in High-Risk Patients: Risk Discussion Framework
Author(s): Francesco Santoro Added: 1 month ago
EHRA Congress 2026 — Dr Francesco Santoro (University of Foggia, Foggia, IT) joins us to explore how electrophysiologists can approach risk assessment and decision-making when considering catheter ablation in high-risk ventricular tachycardia patients — a population where the potential benefits of ablation must be carefully weighed against procedural complexity and patient frailty.Interview… View more

Electrophysiology & Arrhythmia
EHRA 2026: Catheter Ablation vs. AADs for VT in Ischaemic Heart Disease
Author(s): Francesco Santoro Added: 1 month ago
EHRA 2026 — Dr Francesco Santoro joins us to discuss findings from his meta-analysis of randomised controlled trials comparing catheter ablation with anti-arrhythmic drug therapy in patients with ventricular tachycardia and ischaemic heart disease.This meta-analysis pooled data from four RCTs enrolling 947 patients with ischaemic heart disease and ICD implantation, randomised to either catheter… View more

Electrophysiology & Arrhythmia
EHRA 25: The European Affera Ventricular Arrhythmia Ablation Registry
Author(s): Frédéric Sacher Added: 1 year ago
EHRA 2025 - Positive safety results of the Affera mapping and ablation system for the treatment of ventricular arrhythmias (VA) show a 6% rate of major complication.Dr Frédéric Sacher (IHU Liryc, Bordeaux, FR) joins us on-site at EHRA Congress 2025 to discuss safety results from the European Affera Ventricular Arrhythmia Ablation Registry, investigating VA ablation with the Affera Sphere-9… View more

Electrophysiology & Arrhythmia
EHRA 2026: Real-World Mortality Outcomes With PFA vs Thermal Ablation
Author(s): Roland R Tilz Added: 1 month ago
EHRA Congress 2026 – Prof Roland Tilz (University Hospital Schleswig-Holstein, Lübeck, DE) presents the findings from the TiFFANY-AF study, a retrospective observational analysis evaluating real-world mortality outcomes associated with pulsed field ablation compared with thermal ablation techniques — radiofrequency and cryoballoon — for atrial fibrillation.Drawing on a decade of data from the US… View more

Electrophysiology & Arrhythmia
Pulsed Field Ablation for Ventricular Arrhythmias: Current Evidence
Author(s): Serge Boveda , Andrea Sarkozy Added: 4 months ago
In the latest episode of Arrhythmia Academy’s Journal Club, Dr Serge Boveda (Clinic Pasteur, FR) is joined by Professor Andrea Sarkozy (Brussels South University Hospital, BE) to explore the evolving role of pulsed field ablation (PFA) in the treatment of ventricular arrhythmias.The discussion focuses on the potential of PFA as a novel energy source in the ventricle, examining its ability to… View more

Electrophysiology & Arrhythmia
HRS 2026: Six-Month Outcomes from the Sphere-9 VT Early Feasibility Study
Author(s): Pasquale Santangeli Added: 1 week ago
HRS Congress 2026 — In this Arrhythmia Academy expert interview, Brad Wilson, Director of Medical Device Partnerships at Radcliffe and Arrhythmia Academy, speaks with Dr. Pasquale Santangeli (Cleveland Clinic, Ohio, USA) about six-month outcomes from the Sphere-9 VT early feasibility study.They review the Affera Sphere-9 lattice tip catheter and mapping-ablation system, a dual-energy, large… View more

Electrophysiology & Arrhythmia